osteosarcoma
Search results
Scope
Date
~
-
Bio & Pharma
MedPacto's anti-cancer substance designated as US FDA fast-track item
South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...
Jan 18, 2023 (Gmt+09:00)
1
Latest News
- 1 NPS-backed new prime office struggles with poor demand
- 2 Affinity-backed SSG.COM offers first voluntary redundancy
- 3 Lotte to cut basic chemicals in portfolios for profitability
- 4 Young rich Koreans: Financially literate, self-directing
- 5 LG Elec logs record Q2 profit on home appliances, car parts